Skip to Main Content

An official website of the United States government

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Multiplexed Assay of Serum Biomarkers for Pancreatic Cancer

Datasets


Site: Pancreas

Inclusion Criteria:

  • No History of Pancreatic Cancer
  • No Rare Cancers in Controls
  • Pre-Diagnostic Serum Available (Perfect for Controls)
  • Pre-Diagnostic Serum within 3 years of Dx for Cases
  • No Endocrine Pancreatic Cancers

Matching Factors:

  • Gender
  • Age at Serum Collection (5 year intervals)
  • Calendar Year of Serum Collection
  • Study Year of Serum Collection

Match Ratio: 4 to 1

Match Technique: Frequency matching only non-cases as controls.


Analytes:

  • Brain-Derived Neurotrophic Factor
  • Cancer Antigen 19-9
  • Cancer Antigen 72-4
  • Carcinoembryonic antigen
  • Follicle Stimulating Hormone
  • Growth Hormone
  • Osteocalcin
  • Osteopontin
  • Osteoprotegerin
  • Plasminogen activator inhibitor-1

Number of Cases: 135

Number of Controls: 540